EUVIMEDEUVIMED entdecken
LeserbriefOpen Access

Post‐Transplant Circulating Tumor DNA and Recurrence Risk After Liver Transplantation for Hepatocellular Carcinoma

Sara Shahrestani, Mukund Karthik, Sander S Florman, Myron Schwartz, Parissa Tabrizian

Clinical Transplantation · 2026-07 · 40 (7)

DOI: 10.1111/ctr.70615 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Clinical Transplantation, online erschienen am 09.07.2026. Verfasst von Sara Shahrestani und 4 weiteren Autor:innen. Beteiligte Einrichtung: Recanati/Miller Transplantation Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Recanati/Miller Transplantation Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Sydney Medical School, University of Sydney, Sydney, Australia.

Zitieren

APA

Shahrestani, S., Karthik, M., Florman, S. S., Schwartz, M., & Tabrizian, P. (2026). Post‐Transplant Circulating Tumor DNA and Recurrence Risk After Liver Transplantation for Hepatocellular Carcinoma. Clinical Transplantation, 40(7). https://doi.org/10.1111/ctr.70615

Vancouver

Shahrestani S, Karthik M, Florman SS, Schwartz M, Tabrizian P. Post‐Transplant Circulating Tumor DNA and Recurrence Risk After Liver Transplantation for Hepatocellular Carcinoma. Clinical Transplantation. 2026;40(7). doi:10.1111/ctr.70615

BibTeX
@article{Shahrestani2026,
  author = {Shahrestani, Sara and Karthik, Mukund and Florman, Sander S and Schwartz, Myron and Tabrizian, Parissa},
  title = {Post‐Transplant Circulating Tumor DNA and Recurrence Risk After Liver Transplantation for Hepatocellular Carcinoma},
  journal = {Clinical Transplantation},
  year = {2026},
  volume = {40},
  number = {7},
  doi = {10.1111/ctr.70615}
}
Kostenlos starten →